PHAXIAM Therapeutics S.A. Cash Flow Reinvestment Rate

Latest as of December 2012: 0.08x

PHAXIAM Therapeutics S.A. cash flow reinvestment rate. PHAXIAM Therapeutics S.A. (PHXM) has a Cash Flow Reinvestment Rate of 0.08x as of December 2012, reinvesting €48.40K (capex €48.40K ) from operating cash flow of €621.40K. Explore PHAXIAM Therapeutics S.A. cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.08x

(Capex + Investments) / Operating CF

Total Reinvested

€48.40K

Capex + Investments

Operating Cash Flow

€621.40K

EUR

Capital Expenditures

€48.40K

EUR

Cash Flow Reinvestment Rate of PHAXIAM Therapeutics S.A. (2012–2012)

Cash flow reinvestment rate of PHAXIAM Therapeutics S.A. from 2012 to 2012. Historical reinvestment intensity for PHAXIAM Therapeutics S.A. across 1 annual periods. Explore PHAXIAM Therapeutics S.A. capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

PHAXIAM Therapeutics S.A. Cash Flow Reinvestment Rate by Year (2012–2012)

PHAXIAM Therapeutics S.A. cash flow reinvestment rate by year from 2012 to 2012. Year-by-year capital reinvestment analysis for PHAXIAM Therapeutics S.A.. For the full cash flow conversion analysis, see PHXM cash flow conversion.

Year	Reinvestment Rate	Total Reinvested (EUR)	Operating CF	Capex	YoY Change
2012	0.08x	€52.50K	€621.40K	€52.50K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow